Pharmaceutical research and development executive with significant accomplishments across all phases of development and different therapeutic areas. Significant experience in global drug development, regulatory submissions and organizational leadership. Significant contributions to over 40 INDs and 9 NDAs including Abilify, Benicar HCT, Azor, Tribenzor, Welchol and Effient. He is currently serving with Brace Pharma Capital as Vice President.
Specialties: Clinical pharmacology, translational science, pharmacokinetics, pharmacometrics molecular pharmacology, pharmacogenomics, clinical development, regulatory expertise, biomarkers, digital health